Font Size: a A A
Keyword [second line treatment]
Result: 1 - 20 | Page: 1 of 4
1. Comparative Study Of EML4-ALK Gene Expression In NSCLC Treated With Second-line Chemotherapy And Targeted Therapy Of Wild Type NSCLC
2. Effect Of Common EGFR Mutant Genotype On Second - Line Treatment Strategy Of Advanced Lung Adenocarcinoma
3. Clinical Study Of Shenqi Fuzheng Injection With Pemetrexed On Second-Line Treatment Of Advanced Stage Non-Small Cell Lung Cancer
4. Clinical Observation Of Pemetrexed Monotherapy Or Combination Regimen As Second-line Treatment For Advanced Non-small Cell Lung Cancer
5. Clinical Observation In Second-Line Treatment Of Advanced Non-Small Cell Lung Cancer Of Pemetrexed Compared With Gefitinib
6. The Analysis Of Prognostic Determinants And The Therapeutic Effect Of Second-line Regimen Of 298 Cases Of Advanced NSCLC
7. The Chemotherapy Efficacy And Prognosis Analysis Of Advanced Non Small Cell Lung Cancer
8. The Relationship Between Epithelial-mesenchymal Transition, The Expression Of IGF-1R And Efficacy Of Gefitinib As The Second Line Treatment For Advanced Non-small Cell Lung Cancer
9. Efficacy And Cost-effectiveness Analysis Of The Second-line Treatment For Advanced Non-small-cell Lung Cancer
10. The Detection Of Egfr And Emt, And Its Relationship With The Efficacy Of Egfr-Tkis As The Second Line Treatment In Advanced Nsclc
11. Advanced Non Small Cell Lung Cancer Maintenance Treatment Prognostic Analysis Of Second-line Therapy
12. Meta-analysis Of Pemetrexed\Docetaxel And Platinum Doublet Versus Monotherapy As Second-line Treatment For Advanced Non-small-cell Lung Cancer
13. The Clinical Analysis Of The Efficacy And Safety Of FOLFIRI Scheme As Second-line Treatment For Advanced Gastric Adenocarcinoma
14. A Clinical Study Of The Effect Of EGFR Mutations On Targeting Therapy As Second Line Treatment In Advanced Non-small Cell Lung Cancer(NSCLC)
15. The Clinical Study Of First And Second Line Treatment Of Irinotecan Combined With Platinum In Small Cell Lung Cancer
16. Economic Evaluation Of Bevacizumab Combined With Chemotherapy As A Second-line Treatment For Metastatic Colorectal Cancer
17. Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
18. Efficacy And Safety Of Raltitrexed As Second-line Treatment For Advanced Gastric Carcinoma
19. An Exploratory Study Of Second-line Treatment For Bone Metastatic In Breast Cancer With A Loading Dose Of Ibandronate
20. A Systematic Review:Comparison Of Platinum-based Doublet Versus Non-Platinum Single-agent As Second-line Treatment Of Advanced Non-Small-Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to